A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC).

被引：43
|
作者：
Hong, Min Hee
Kim, HyeRyun
Park, Seong Yong
Kim, Dae Joon
Lee, Chang Geol
Cho, Jaeho
Kim, Jong Hoon
Kim, Hyeong Ryul
Kim, Yong-Hee
Park, Sook Ryun
Cho, Byoung Chul
机构：
[1] Yonsei Univ, Coll Med, Div Med Oncol, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Thorac & Cardiovascular Surg, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Radiat Oncol, Yonsei Canc Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Dept Radiat Oncol, Asan Med Ctr, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Dept Thorac & Cardiovasular Surg, Asan Med Ctr, Seoul, South Korea
[6] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4027
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
    Bin Yao
    Bingxu Tan
    Cong Wang
    Qingxu Song
    Jianbo Wang
    Shanghai Guan
    Yibin Jia
    Yanan Ma
    Xiaochen Huang
    Yi Sun
    Yufeng Cheng
    Annals of Surgical Oncology, 2016, 23 : 2367 - 2372
  • [22] Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
    Yao, Bin
    Tan, Bingxu
    Wang, Cong
    Song, Qingxu
    Wang, Jianbo
    Guan, Shanghai
    Jia, Yibin
    Ma, Yanan
    Huang, Xiaochen
    Sun, Yi
    Cheng, Yufeng
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (07) : 2367 - 2372
  • [23] The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
    Lo, Chien-Ming
    Wang, Yu-Ming
    Chen, Yen-Hao
    Fang, Fu-Min
    Huang, Shun-Chen
    Lu, Hung-, I
    Li, Shau-Hsuan
    CURRENT ONCOLOGY, 2021, 28 (02) : 1354 - 1365
  • [24] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Updated data from a prospective, phase II trial
    Chen, Yueyun
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    Ding, Zhen-Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
    Guo, Jhe-Cyuan
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chia-Chi
    Hsu, Feng-Ming
    Cheng, Jason Chia-Hsien
    Huang, Yen-Lin
    Hsieh, Min-Shu
    Huang, Pei-Ming
    Lee, Jang-Ming
    Wu, Shu-Ling
    Hsu, Chih-Hung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [26] Adjuvant chemoradiotherapy (CRT) plus pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) with high risk of recurrence after neoadjuvant CRT plus surgery: A single-arm phase II study
    Guo, Jhe-Cyuan
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chia-Chi
    Hsu, Feng-Ming
    Cheng, Jason C.
    Huang, Yen-Lin
    Hsieh, Min-Shu
    Huang, Pei-Ming
    Lee, Jang-Ming
    Wu, Shu-Ling
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 320 - 320
  • [27] Preoperative chemoradiotherapy and surgery for locally advanced esophageal basaloid squamous carcinoma: Report of successful
    Hyodo M.
    Hosoya Y.
    Arai W.
    Yokoyama T.
    Shibusawa H.
    Yasuda Y.
    Nagai H.
    Shibayama C.
    Nakazawa M.
    Esophagus, 2005, 2 (2) : 85 - 89
  • [28] A phase II study of chemoradiotherapy in patients with stage II, III esophageal squamous cell carcinoma (ESCC) (JCOG 9906)
    Muro, K.
    Ohtsu, A.
    Ishikura, S.
    Boku, N.
    Takiuchi, H.
    Saito, H.
    Kaneko, K.
    Miyata, Y.
    Komatsu, Y.
    Shirao, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Preoperative chemoradiotherapy with S-1 followed by surgery in patients with locally advanced oral squamous cell carcinoma: A prospective phase II trial
    Nagata, Masashi
    Nakayama, Hideki
    Kawahara, Kenta
    Tanaka, Takuya
    Nakagawa, Yoshihiro
    Yoshida, Ryoji
    Hirosue, Akiyuki
    Yoshitake, Yoshihiro
    Ota, Kazutoshi
    Hiraki, Akimitsu
    Shinohara, Masanori
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S35 - S35
  • [30] Phase II trial of endostar in combination with concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of esophagus
    Qi, Y.
    Wei, S.
    Shao, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S867 - S867
12345